- Poster presentation
- Open Access
Mouse model of specific fragrance allergy: the haptenous state determines site-specific tolerance or allergy
© Roth-Walter et al; licensee BioMed Central Ltd. 2014
- Published: 17 March 2014
- Physical Activity
- Body Temperature
- Cytokine Response
- Cytokine Profile
- Oral Route
Cinnamon aldehyde (CA) represents a ubiquitous fragrance being respired, contacted by skin or consumed via the oral route and it may lead to type I. and IV. hypersensitivity. Here, we sought to investigate whether the encounter of CA as a hapten or coupled to a carrier influences whether the organism responds allergic or tolerant.
Cinnamaldehyde (CA) alone, or conjugated with keyhole limpet hemocyanin (CA-KLH) was applied nasally six times on two consecutive days in biweekly intervals. Subsequently, ears were painted with cinnamaldehyde and ear swelling measured after 24 and 48h. Mice were also challenged by oral gavage of 2mg CA and body temperature was measured for 30min. Cytokine profile of stimulated splenocytes as well as CA-specific antibodies and corticosteron-levels were assessed by ELISA.
Only in mice sensitized with CA-KLH a specific immune response with CA-specific IgG1, IgE, IgG2a and IgA levels as well as elevated IFNγ could be observed. CA-KLH sensitized mice also showed significant ear swelling response to CA after 24h. However, CA-KLH mice were protected from anaphylaxis upon oral challenge. In contrast, although no specific antibody and cytokine response could be detected in mice sensitized with the hapten CA only, 40% reacted upon oral challenge with CA by an anaphylactic decrease in body temperature and decreased physical activity and. In contrast, they were unresponsive upon epicutaneous challenge with CA. Interestingly, corticosteron levels of CA-sensitized mice were the lowest between the groups.
We conclude that fragrances may via the nasal route indeed lead to specific type I hypersensitivity, but that the type and extent of response is critically determined by their antigenic state - hapten or complete antigen.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.